Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate and Exercise for Cancer-Related Fatigue in Prostate Cancer
NCT03772834Phase 3Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2019
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate hydrochloride extended-release chewable tablet in cancer-related fatigue (CRF), sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2019; status: active, not recruiting.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT03772834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03772834.